O.P. Purohit - Concepedia

Author

O.P. Purohit

Also Known As

O P Purohit, O. P. Kash Purohit, O. P. Purohit, O. P.-K. Purohit, O. Prakash Purohit, O. Purohit, O.-P. Purohit, O.P Purohit, O.P. Purohit, Om Purohit

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Weston Park Cancer Centre University of Sheffield St James's University Hospital Yorkshire Cancer Research Western General Hospital

About

O.P. Purohit is an author at Weston Park Cancer Centre specializing in medicine, orthopaedics, and bone health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	511
2	Orthopaedics	7	7	467
3	Pharmacology	5	5	285
4	Health Sciences	4	4	241
5	Cancer Therapeutics	1	1	44

O.P. Purohit

Publications

983

Citations

H-Index

Page 1

	Year	Citations
Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer J. Lester, David Dodwell, O.P. Purohit, Clinical Cancer Research	2008	189
Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease J. Vinholes, O.P. Purohit, Mavis Abbey, Annals of Oncology Bone DiseaseBone HealthOrthopaedic SurgeryMedicineSymptomatic Response	1997	169
Bone resorption predicts for skeletal complications in metastatic bone disease Janet E. Brown, C S Thomson, Sue Ellis, British Journal of Cancer	2003	165
Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease S. Jagdev, O.P. Purohit, Sarah Heatley, Annals of Oncology Bone DiseaseBone HealthBone ResorptionIntravenous PamidronateOsteoporosis	2001	109
Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease Robert E. Coleman, O.P. Purohit, Casilda G. Black, Annals of Oncology Dose-finding StudyBone DiseaseBone HealthOral IbandronateMetastatic Bone Disease	1999	95
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. J. Vinholes, Chun Guo, O.P. Purohit, Journal of Clinical Oncology	1997	75
Exemestane in metastatic breast cancer: Effective therapy after third-generation non-steroidal aromatase inhibitor failure Nicola Steele, Jamal Zekri, Robert E. Coleman, The Breast Metastatic Breast CancerOncologyBreast OncologyMedicineBreast Cancer	2005	44
A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer Robert E. Coleman, Stephen Houston, O.P. Purohit, European Journal of Cancer Bone DiseaseBone HealthMedicinePharmacologyOral Pamidronate	1998	41
Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial J. Lester, David Dodwell, Janet E. Brown, Journal of bone oncology	2012	25
The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease J. E. Brown, Eugène McCloskey, J Dewar, Calcified Tissue International Bone DiseaseBone HealthBone MarkersMedicineMetastatic Bone Disease	2007	22

Page 1